Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Short term Debt (2022 - 2025)

Historic Short term Debt for Exagen (XGN) over the last 4 years, with Q3 2025 value amounting to $680000.0.

  • Exagen's Short term Debt rose 5813.95% to $680000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $680000.0, marking a year-over-year increase of 5813.95%. This contributed to the annual value of $423000.0 for FY2024, which is 6022.73% up from last year.
  • Per Exagen's latest filing, its Short term Debt stood at $680000.0 for Q3 2025, which was up 5813.95% from $667000.0 recorded in Q2 2025.
  • Over the past 5 years, Exagen's Short term Debt peaked at $2.5 million during Q1 2025, and registered a low of $190000.0 during Q4 2022.
  • Moreover, its 4-year median value for Short term Debt was $345500.0 (2024), whereas its average is $554333.3.
  • Per our database at Business Quant, Exagen's Short term Debt skyrocketed by 551.18% in 2024 and then skyrocketed by 84589.55% in 2025.
  • Quarter analysis of 4 years shows Exagen's Short term Debt stood at $190000.0 in 2022, then surged by 38.95% to $264000.0 in 2023, then skyrocketed by 60.23% to $423000.0 in 2024, then surged by 60.76% to $680000.0 in 2025.
  • Its Short term Debt stands at $680000.0 for Q3 2025, versus $667000.0 for Q2 2025 and $2.5 million for Q1 2025.